A recent Cochrane review estimated GeneXpert MTB/RIF specificity for rifampin resistance as 98% (95% confidence interval [CI], 97 to 99), based on results from earlier test versions. The measured positive predictive value of the new generation test from programmatic implementation in Cape Town, South Africa, was 99.5% (95% CI, 98.5 to 100), confirming excellent specificity.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3911341 | PMC |
| http://dx.doi.org/10.1128/JCM.02517-13 | DOI Listing |
Publication Analysis
Top Keywords
genexpert mtb/rif
8
mtb/rif version
4
version identification
4
identification rifampin-resistant
4
rifampin-resistant tuberculosis
4
tuberculosis programmatic
4
programmatic setting
4
setting cochrane
4
cochrane review
4
review estimated
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!